Since April 2021, Jeane Tsutsui has led the Fleury Group, one of the leading diagnostic medicine companies in Brazil. Her biggest move was the business combination with the Pardini Group, which is expected to capture synergies estimated at up to 220 million reais (US$45 million), in addition to complementing its portfolio and reaching the biggest cities in the country. Tsutsui’s management prevented the leverage level from skyrocketing, in a scenario of inflation and high interest rates.
